American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

December 07, 2023

Newsletter Sponsor

Cell & Gene Therapy Roundtable Part 2: Medical conditions that benefit from cell and gene therapy

The Cell and Gene Therapy documentary explores how these advanced products are changing the healthcare landscape by uncovering treatments that have shown the ability to treat and even cure many individuals with diseases for which there was little to no hope. In this second roundtable discussion, key opinion leaders were asked: "What medical conditions currently benefit the most from cell and gene therapy? Do you see this list growing in the future?" Click to read their answers and learn more.

	Industry News

Visgenx and Charles River Announce Expansion of Gene Therapy Manufacturing Alliance
Visgenx, Inc., a biotechnology company focused on developing gene therapies for degenerative retinal... read more »

FDA Grants Expanded Approval to wilate® as the First VWF Concentrate for Prophylaxis in All Types of VWD
Octapharma USA announced the expansion of the FDA approval for wilate®, von Willebrand Factor/... read more »

Hansa Biopharma Announces Restructuring and Layoffs
Hansa Biopharma announced that it plans to restructure the organization to better align and focus on... read more »

FDA Approves Novartis’ Fabhalta as the First Oral Monotherapy for Adults with PNH
The FDA approved Fabhalta® (iptacopan) as the first oral monotherapy for the treatment of adults ... read more »

	Infographic

API Reference Standard Selection
This infographic outlines essential information for drug developers when choosing a reference material to meet ISO 17034. read more »

	Featured Articles

		Maximizing the Commercialization Potential of Cell and Gene Therapies Dr. Christian K. Schneider, Head of Biopharma Excellence, distils some practical takeaways from a recent panel debate about how those at the forefront... read more »

		Challenges of Analytical Validation for ATMPs Quality Control of medicinal products is a fundamental aspect for assuring the quality, efficacy and safety of the product. Testing of the product at ... read more »

	More Products

708-DS Dissolution Apparatus Learn More
CE 4200 Dual Wavelength UV-Vis Detector Learn More
TSA 3P® Environmental Monitoring Media Learn More

	Directory Categories

Cell Culture Media Search More

Formulation Development Search More

Pharmaceutical Excipients Search More

	Events

PepTalk: The Protein Science Week
San Diego, CA – 01/16/2024
PepTalk 2024 will offer a comprehensive program presenting the latest research and development in the field of protein science and production. ... event details »

Pittcon 2024
San Diego, CA – 02/24/2024
Pittcon is a dynamic, transnational conference and exposition on laboratory science, a venue for presenting the latest advances in analytical research... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA